×
About 3,409 results

ALLMedicine™ Migraine Headache Center

Research & Reviews  1,405 results

Twenty-five years of triptans - a nationwide population study.
https://doi.org/10.1177/0333102421991809
Cephalalgia : an International Journal of Headache; Davidsson OB, Olofsson IA et. al.

Feb 15th, 2021 - The efficacy of triptans as the main acute treatment strategy for migraine headache at the population-wide level needs to be understood to inform clinical decision-making. We summarise key trends in triptan use using more than 25 years of Danish n...

Rimegepant: acute treatment for migraine headaches.
https://doi.org/10.2217/pmt-2020-0090
Pain Management; Peters GL, Hennessey EK

Feb 8th, 2021 - Migraine headache treatment is quickly evolving. There have been three new acute migraine treatment options (i.e., lasmiditan, rimegepant, ubrogepant) and four new preventive migraine treatment options (i.e., erenumab, fremanezumab, galcanezumab, ...

Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patien...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868011
The Journal of Headache and Pain; Ament M, Day K et. al.

Feb 7th, 2021 - Galcanezumab, a humanized monoclonal antibody that binds calcitonin gene-related peptide, has demonstrated a significant reduction in monthly migraine headache days compared with placebo. Here, we analyze data from 3 randomized clinical trials (2 ...

Anti-calcitonin gene-related peptide monoclonal antibodies for neuropathic pain in pati...
https://doi.org/10.1002/mus.27153
Muscle & Nerve REFERENCES; Kang SA, Govindarajan R

Dec 21st, 2020 - There is increasing evidence that calcitonin gene-related peptide (CGRP) plays a role in the development of neuropathic pain, a common feature of peripheral neuropathy. Although clinical studies have shown that anti-CGRP monoclonal antibodies are ...

Migraine Features in Patients With Recurrent Benign Paroxysmal Positional Vertigo.
https://doi.org/10.1097/MAO.0000000000002976 10.1002/lary.28618
Otology & Neurotology : Official Publication of the Ameri... Bruss D, Abouzari M et. al.

Dec 11th, 2020 - To identify migraine features present in a cohort of patients with recurrent benign paroxysmal positional vertigo (BPPV). Patients presenting with recurrent BPPV were surveyed. Recurrent BPPV was defined as three episodes or greater in 6 months be...

see more →

Guidelines  5 results

Acupuncture for Pain
https://www.aafp.org/afp/2019/0715/p89.html
American Family Physician; Kelly,R.,et al

Jul 14th, 2019 - Acupuncture has been increasingly used as an integrative or complementary therapy for pain. It is well-tolerated with little risk of serious adverse effects. Traditional acupuncture and nontraditional techniques, such as electroacupuncture and dry...

Altered Brain Structure and Function Correlate with Disease Severity and Pain Catastrophizin...
http://www.eneuro.org/content/1/1/ENEURO.0006-14.2014
Catherine S. Hubbard

Nov 11th, 2014 - To investigate the neuroanatomical and functional brain changes in migraine patients relative to healthy controls, we used a combined analytical approach including voxel- and surface-based morphometry along with resting-state functional connectivi.

Canadian Headache Society Guideline: acute drug therapy for migraine headache.
https://www.ncbi.nlm.nih.gov/pubmed/23968886
The Canadian Journal of Neurological Sciences. Le Journal... Worthington I, Pringsheim T et. al.

Oct 22nd, 2013 - The primary objective of this guideline is to assist the practitioner in choosing an appropriate acute medication for an individual with migraine, based on current evidence in the medical literature and expert consensus. It is focused on patients ...

Evidence-based guideline update: NSAIDs and other complementary treatments for episodic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335449
Neurology Holland S, Silberstein SD et. al.

Apr 24th, 2012 - To provide updated evidence-based recommendations for the preventive treatment of migraine headache. The clinical question addressed was: Are nonsteroidal anti-inflammatory drugs (NSAIDs) or other complementary treatments effective for migraine pr...

Evidence-based guideline update: pharmacologic treatment for episodic migraine preventi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335452
Neurology Silberstein SD, Holland S et. al.

Apr 24th, 2012 - To provide updated evidence-based recommendations for the preventive treatment of migraine headache. The clinical question addressed was: What pharmacologic therapies are proven effective for migraine prevention? The authors analyzed published stu...

see more →

Drugs  181 results see all →

Clinicaltrials.gov  1,677 results

Sumatriptan - sumatriptan succinate tablet-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=62ba6fef-467a-4500-993c-51907f12a67c

Feb 21st, 2021 - Sumatriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine a...

Sumatriptan - sumatriptan succinate tablet-Quality Care Products, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5d1f3de0-684a-4092-be30-aa325ff20d04

Feb 18th, 2021 - Sumatriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine a...

Sumatriptan - sumatriptan succinate tablet-Quality Care Products, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c3812a3-872e-42c1-98a4-f6faa43bb7cb

Feb 17th, 2021 - Sumatriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine a...

Sumatriptan - sumatriptan succinate tablet-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=85295be9-852d-4e21-e053-2991aa0a8a78

Feb 16th, 2021 - Sumatriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine a...

Twenty-five years of triptans - a nationwide population study.
https://doi.org/10.1177/0333102421991809
Cephalalgia : an International Journal of Headache; Davidsson OB, Olofsson IA et. al.

Feb 15th, 2021 - The efficacy of triptans as the main acute treatment strategy for migraine headache at the population-wide level needs to be understood to inform clinical decision-making. We summarise key trends in triptan use using more than 25 years of Danish n...

see more →

News  139 results

Headache Day 'Threshold' for Chronic Migraine Called Into Question
https://www.medscape.com/viewarticle/932745

Jun 21st, 2020 - People with high-frequency episodic migraine and low-frequency chronic migraine may have similar treatment needs because characteristics of the two disorders overlap significantly, calling into question the existing threshold of 15 migraine headac...

Headache May Predict Clinical Evolution of COVID-19
https://www.medscape.com/viewarticle/932637

Jun 18th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Headache may be a key symptom of COVID-19 that predicts the disease's clinical evolution in individual patients, new research suggests. An observa...

Migraine and Non-Migraine headache show no association with all-cause mortality in women
https://www.mdedge.com/neurology/migraineresourcecenter/article/220121/headache-migraine/migraine-and-non-migraine-headache?channel=63462

Apr 2nd, 2020 - Key clinical points: Migraine and non-migraine headache show no association with all-cause mortality; however, the risk of cardiovascular mortality is higher in women experiencing from migraine with aura. Major finding: All-cause mortality did not.

Higher Prevalence of Migraine in Women with Endometriosis
https://www.mdedge.com/neurology/migraineresourcecenter/article/217469/headache-migraine/higher-prevalence-migraine-women?channel=222

Feb 18th, 2020 - Key clinical point: Women of reproductive age experiencing migraines should be screened for endometriosis. Major finding: Migraine headache was more frequent in women with endometriosis than in those without endometriosis (35.

Burden of White Matter Hyperintensities in Patients with Sporadic Hemiplegic Migraine
https://www.mdedge.com/neurology/migraineresourcecenter/article/207607/headache-migraine/burden-white-matter?channel=63462

Sep 5th, 2019 - The white matter hyperintensities (WMH) in patients with sporadic hemiplegic migraine (SHM) is significantly more in the parietal lobe when compared with those with migraine headaches, a new study found. Fifty patients met the criteria for SHM and.

see more →

Patient Education  2 results see all →